Compare FMNB & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FMNB | CADL |
|---|---|---|
| Founded | 1887 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 857.4M | 694.6M |
| IPO Year | 2010 | 2021 |
| Metric | FMNB | CADL |
|---|---|---|
| Price | $16.35 | $11.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $15.00 | ★ $19.00 |
| AVG Volume (30 Days) | 410.3K | ★ 1.1M |
| Earning Date | 04-22-2026 | 05-14-2026 |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | 18.85 | ★ 58.62 |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $279,922,000.00 | $125,000.00 |
| Revenue This Year | $52.63 | N/A |
| Revenue Next Year | $8.28 | N/A |
| P/E Ratio | $21.25 | ★ N/A |
| Revenue Growth | ★ 3.89 | N/A |
| 52 Week Low | $12.23 | $4.35 |
| 52 Week High | $16.18 | $11.36 |
| Indicator | FMNB | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 72.34 | 71.02 |
| Support Level | $13.75 | $9.18 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.27 | 0.52 |
| MACD | 0.03 | 0.09 |
| Stochastic Oscillator | 99.62 | 99.07 |
Farmers National Banc Corp is a financial holding company based in the U.S. Along with its subsidiaries, it operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The group offers a full range of commercial and retail banking services, including checking accounts, savings accounts, time deposit accounts, commercial, mortgage, and installment loans, safe deposit boxes, ATMs, internet banking, and other banking services. Additionally, it offers personal and corporate trust services in the areas of estate settlement, trust administration, employee benefit plans, and retirement services; insurance products, and other financial products and services. The group's reportable segments are Bank, which generates the maximum revenue, and Trust.
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.